Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Now Available Global Microbiome Therapeutics Market Forecast And Growth 2017-2027

141 views

Published on

Future Market Insights has announced the addition of the “Microbiome Therapeutics: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.

Published in: Business
  • Be the first to comment

Now Available Global Microbiome Therapeutics Market Forecast And Growth 2017-2027

  1. 1. Microbiome Therapeutics Market To Make Great Impact In Near Future by 2027 February 2017 ©2015 Future Market Insights, All Rights Reserved Report Id : REP-GB-2831 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices
  2. 2. About Future Market Insights ©2015 Future Market Insights, All Rights Reserved Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Subscription Information  Customized Research  Syndicated Research  Investment Research  Social Media Research Sector Coverage  Automotive and Transportation  Electronics, Semiconductor, and ICT  Retail and Consumer Products  Industrial Automation and Equipment  Chemicals & Materials  Food and Beverages  Services and Utilities  Energy, Mining, Oil, and Gas For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Customized Research Syndicated Research Investment Research Social Media Research 2
  3. 3. Research Methodology (1/2) Systematic Research Approach In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts PMR conducts interviews with industry experts, industry players, distributors and retailers Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF) Data Collection Data Filter & Analysis Research & Intelligence Actionable Insights Business Solution A C B Primary Research Company Analysis Desk Research  Identifying key opinion leaders  Questionnaire design  In-depth interviews  Coverage across value chain  Market participants  Key strengths  Product portfolio  Mapping as per value chain  Key focus segments  Key industry experts  Channel study  Developments  Market dynamics  Products  Conclusions SOLUTION Primary Research#  Linkedin  Zoominfo  Salesforce  Avention  Factiva  GBI  Genios  Meltwater  Company websites  Company annual reports  White papers  Financial reports ©2015 Future Market Insights, All Rights Reserved Secondary Research # Paid Publications# Insights Market profiling Formulating discussion guide Developing list of respondents Data analysis Data validation Data collection 1 2 3 4 5 6 7 # includes sources of databases 3
  4. 4. Microbiome refers to the collection or community of microbes. Microbial community that presented in our body has major impact on the body functions from digestion to immune conditions. Millions of microbes are present in our digestive tract, oral cavity, respiratory mucosa, skin and other parts of the body. In recent years, research on microbiome increased over the years to know benefits associated with microbes on the host. In microbiome therapeutics probiotics, prebiotics and synbiotics play a vital role in diagnosis, prevention, and treatment of various disease conditions. Probiotics are microorganisms such as bacteria, yeasts that provide health benefits when they consumed. Prebiotics are non-digestible carbohydrate that helps in growth of microbes that are present in the body. The combination of probiotics and prebiotics called as Synbiotics. However, till date, there was no microbiome related product in the market that was approved by U.S. FDA to treat any specific indication. The most beneficial factor for microbiome therapeutics is they didn’t cause any side effects unlike the drug molecules as they already reside in the body. Hence, they are gaining traction from many small and big companies to explore its benefits on various disease indications like prevention of oral biofilm, Crohn's disease, Irritable bowel syndrome conditions that don’t have any proper treatment. Vedanta Biosciences, a startup working on Clostridium strains (VE-202) to treat IBD and Crohn’s disease conditions. In January 2015, Johnson and Johnson signed the license agreement with Vedanta Biosciences to acquire rights for the investigational drug to treat IBD conditions. Synologic involved in the development of medicines from microbiome platform collaborated with AbbVie to develop the drug for inflammatory bowel disease. Microbiome Therapeutics Market: Drivers and Restraints The major drivers for microbiome therapeutics market are raise in digestive related disorders, increase in x Microbiome Therapeutics Market ©2015 Future Market Insights, All Rights Reserved 4
  5. 5. drug-related side effects, helpful in the treatment of disease conditions that don’t have treatments, non- immunogenic and can be used as dietary supplements to improve overall health. Barriers for the microbiome therapeutics market is they are expensive due to its complex process to develop and extract the bacteria in the laboratory. In addition to the aforementioned factors, microbiomes are heat sensitive, and lack of proper regulations are hindering the growth of this market. Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2831 Microbiome Therapeutics Market Market: Segmentation The global microbiome therapeutics market is classified on the basis of product, distribution channel, application area and geography. Based on product type, the microbiome therapeutics market is segmented into the following:  Probiotics  Prebiotics  Synbiotics Microbiome Therapeutics Market ©2015 Future Market Insights, All Rights Reserved 5
  6. 6. Based on distribution channel, the microbiome therapeutics market is segmented into the following:  Hospital Pharmacies  Drug stores  Retail Pharmacies  Super and Hypermarkets  E-commerce stores Based on application area, the microbiome therapeutics market is segmented into the following:  Digestive Health  Respiratory Health  Oral Health Microbiome Therapeutics Market ©2015 Future Market Insights, All Rights Reserved 6
  7. 7.  Immune conditions  Others Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2831 Microbiome Therapeutics Market: Overview In microbiome therapeutics, start-ups are actively working on various disease conditions to develop medicines from microbiome technology platform. Bigger players are interested in inorganic growth by acquisitions, purchasing license agreements or by collaborating with them. In addition to that, government bodies are also actively funding research to various organizations to promote the research on microbiome therapeutics. In May 2016, U.S. federal government announced US$ 121 Mn for Microbiome Initiative, to provide and coordinate funds for microbiome research. Probiotics are expected to have the highest market share over the forecast period due to increase in research on probiotic strains. In the application area, digestive health is projected to have highest market share when compared with other application areas this is mainly attributes to the availability of many products that can treat gastrointestinal conditions. Microbiome Therapeutics Market ©2015 Future Market Insights, All Rights Reserved 7
  8. 8. Microbiome Therapeutics Market: Regional Overview Microbiome Therapeutics Market is classified into seven regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America occupies the significant market share in microbiome therapeutics market due to increasing consumption of dietary supplements and followed by Europe region due to less stringent regulations to market probiotic products into this region when compared with other regions. Japan also accounts to have higher market share next to Europe and North America for probiotics as they are commonly present in various food beverages. Browse Full Report@ http://www.futuremarketinsights.com/reports/microbiome-therapeutics-market Microbiome Therapeutics Market: Players Some of the players in the microbiome therapeutics market Johnson and Johnson, AB-Biotics, Vedanta Biosciences, AbbVie Inc., Dannon, Yakult, Bayer, Ganeden, Sigma-Tau Pharmaceuticals and Pfizer Inc. Microbiome Therapeutics Market ©2015 Future Market Insights, All Rights Reserved 8
  9. 9. ©2015 Future Market Insights, All Rights Reserved Future Market Insights Global & Consulting Private Limited (FMI) Thank You To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Harish Tiwari (General Manager & Global Head Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com 9

×